SIL index, comprising stage, soluble interleukin‐2 receptor, and lactate dehydrogenase, is a useful prognostic predictor in diffuse large B‐cell lymphoma

по Tomita, Naoto, Sakai, Rika, Fujisawa, Shin, Fujimaki, Katsumichi, Taguchi, Jun, Hashimoto, Chizuko, Ogawa, Koji, Yamazaki, Etsuko, Ishigatsubo, Yoshiaki
Опубликовано в: Cancer Sci (2012)

Changing trends in prognostic factors for patients with multiple myeloma after autologous stem cell transplantation during the immunomodulator drug/proteasome inhibitor era

по Takamatsu, Hiroyuki, Honda, Sumihisa, Miyamoto, Toshihiro, Yokoyama, Kenji, Hagiwara, Shotaro, Ito, Toshiro, Tomita, Naoto, Iida, Shinsuke, Iwasaki, Toshihiro, Sakamaki, Hisashi, Suzuki, Ritsuro, Sunami, Kazutaka
Опубликовано в: Cancer Sci (2015)

Post-treatment PET–CT Findings may Predict the Prognosis of DLBCL with a Bulky Mass

по Takasaki, Hirotaka, Yamamoto, Wataru, Ishii, Yoshimi, Takahashi, Hiroyuki, Watanabe, Reina, Harada, Taishi, Kawasaki, Rika, Hashimoto, Chizuko, Motomura, Shigeki, Tomita, Naoto, Ishigatsubo, Yoshiaki, Sakai, Rika
Опубликовано в: Indian J Hematol Blood Transfus (2014)

Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations

по Tomita, Naoto, Tokunaka, Mami, Nakamura, Naoya, Takeuchi, Kengo, Koike, Junki, Motomura, Shigeki, Miyamoto, Ko, Kikuchi, Ako, Hyo, Rie, Yakushijin, Yoshihiro, Masaki, Yasufumi, Fujii, Soichiro, Hayashi, Takamasa, Ishigatsubo, Yoshiaki, Miura, Ikuo
Опубликовано 2009

MIB‐1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy

по Yamamoto, Eri, Tomita, Naoto, Sakata, Seiji, Tsuyama, Naoko, Takeuchi, Kengo, Nakajima, Yuki, Miyashita, Kazuho, Tachibana, Takayoshi, Takasaki, Hirotaka, Tanaka, Masatsugu, Hashimoto, Chizuko, Koharazawa, Hideyuki, Fujimaki, Katsumichi, Taguchi, Jun, Harano, Hiroshi, Motomura, Shigeki, Ishigatsubo, Yoshiaki
Опубликовано в: Cancer Sci (2013)

European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients

по Yamamoto, Eri, Fujisawa, Shin, Hagihara, Maki, Tanaka, Masatsugu, Fujimaki, Katsumichi, Kishimoto, Kumiko, Hashimoto, Chizuko, Itabashi, Megumi, Ishibashi, Daisuke, Nakajima, Yuki, Tachibana, Takayoshi, Kawasaki, Rika, Kuwabara, Hideyuki, Koharazawa, Hideyuki, Yamazaki, Etsuko, Tomita, Naoto, Sakai, Rika, Fujita, Hiroyuki, Kanamori, Heiwa, Ishigatsubo, Yoshiaki
Опубликовано в: Cancer Sci (2014)